Merck asks EU regulator to authorize its COVID-19 pill
AMSTERDAM (AP) — The European Medicines Agency says it has received a request from Merck to authorize its coronavirus antiviral, the first pill shown to treat COVID-19. In a statement Tuesday, the EU drug regulator said it had started evaluating molnupiravir, made by Merck and Ridgeback Biotherapeutics, and that a decision could be made within
Continue Reading